Bupropion is one of the most common prescription medications to trigger a false positive on a urine drug test, specifically for amphetamines. In one study published in the Journal of Medical Toxicology, 35% of initial positive amphetamine screens failed to confirm on more advanced testing, and bupropion was the identified cause in 41% of those unconfirmed results. If you take bupropion (sold as Wellbutrin, Zyban, or generic versions) and have an upcoming drug screening, this is a well-documented problem with a straightforward solution.
Why Bupropion Triggers Amphetamine Screens
Most workplace and clinical drug tests start with a type of screening called an immunoassay. These tests use antibodies designed to bind to amphetamine molecules. The problem is that bupropion and two of its breakdown products, called erythrohydrobupropion and threohydrobupropion, have chemical structures similar enough to amphetamine that they can bind to the same antibodies. The test essentially mistakes your antidepressant for an illegal stimulant.
This isn’t a flaw unique to one brand or formulation of bupropion. It’s a consequence of the drug’s core chemical structure, which belongs to the same broad family of compounds as amphetamines. Your liver breaks bupropion down into several active metabolites, and some of those metabolites are the ones most likely to cross-react with the screening antibodies. Because these metabolites can linger in your system for hours after your last dose, the timing of your test relative to when you took your medication can influence whether a false positive occurs.
How Often It Actually Happens
Exact prevalence numbers depend on which screening test a lab uses. One widely used immunoassay platform, the Syva EMIT II, has been specifically called out in research for its cross-reactivity with bupropion and related psychotropic medications. In the Journal of Medical Toxicology study, researchers reviewed 362 urine samples that initially screened positive for amphetamines. When those samples went through gas chromatography (a much more precise method), 234 samples (65%) were confirmed as true positives for amphetamines. The remaining 128 (35%) were false positives. Of those false positives, 53 patients, or 41%, had bupropion listed in their medical records.
That means bupropion was the single largest identifiable cause of false positive amphetamine results in that dataset. Not every bupropion user will trigger a false positive on every test, but if you do get a positive amphetamine result and you take bupropion, there’s a strong chance the medication is responsible.
Research has also documented that bupropion can interfere with screens for LSD, though this is less commonly discussed and less likely to come up in standard workplace panels.
What Happens After a Positive Screen
A standard drug testing protocol has two steps. The first is the immunoassay screening, which is fast and cheap but not very specific. If it comes back positive, a second confirmatory test is run using gas chromatography or a similar technique that identifies the exact molecules in the sample. This confirmatory test can reliably distinguish bupropion and its metabolites from actual amphetamines or methamphetamine.
In the study described above, every single bupropion-related false positive was caught at the confirmation stage. The confirmatory test is essentially foolproof for this particular issue. The concern isn’t that bupropion will lead to a confirmed positive. It’s that the process can be stressful, cause delays, or create awkward conversations with an employer before the confirmation comes back.
How to Protect Yourself
The simplest step is to disclose your bupropion prescription before the test. Most drug testing programs, whether for employment, probation, or clinical purposes, have a process for this. You’ll typically provide your information to a Medical Review Officer (MRO), a licensed physician who reviews drug test results. If your initial screen comes back positive for amphetamines and you’ve disclosed bupropion use, the MRO will order confirmatory testing and interpret the result in context.
You can also take these practical steps:
- Bring documentation. A pharmacy printout or prescription bottle showing your name, the medication, and the prescribing physician is usually sufficient.
- Disclose proactively. Tell the testing facility or MRO about your prescription before providing your sample, not after a positive result. This avoids the appearance of making excuses after the fact.
- Request confirmatory testing. If you receive a positive amphetamine result and confirmatory testing isn’t automatically performed, you have the right to request it. Gas chromatography will definitively show that no amphetamines are present.
Which Tests Are Most Likely to Be Affected
Not all immunoassay platforms are equally susceptible. The EMIT II system has been specifically identified as having poor selectivity for amphetamine and methamphetamine, making it more prone to cross-reactivity with bupropion. Other immunoassay platforms may perform better, but because you typically won’t know which system a lab uses, it’s safest to assume the risk exists with any standard urine drug screen.
Point-of-care tests, including the cup-style rapid tests sometimes used in urgent care settings or by employers who want same-day results, tend to use similar antibody-based technology and carry the same risk. Laboratory-based immunoassays are no different in this respect. The only type of test that won’t produce a false positive from bupropion is a confirmatory method like gas chromatography or liquid chromatography paired with mass spectrometry, which identifies substances by their exact molecular weight rather than by antibody binding.
If you’re taking bupropion at any dose, the possibility of a false positive amphetamine result on a standard urine screen is real and well-documented. The good news is that confirmatory testing resolves it every time, and disclosing your prescription ahead of time keeps the process from becoming a problem.